Nova Leap Health Stock Price To Sales
| NLH Stock | CAD 0.25 0.01 3.85% |
Nova Leap Health fundamentals help investors to digest information that contributes to Nova Leap's financial success or failures. It also enables traders to predict the movement of Nova Stock. The fundamental analysis module provides a way to measure Nova Leap's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nova Leap stock.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 0.67 | 0.64 |
Nova | Price To Sales |
Nova Leap Health Company Price To Sales Analysis
Nova Leap's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Nova Leap Price To Sales | 0.84 X |
Most of Nova Leap's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nova Leap Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Nova Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for Nova Leap is extremely important. It helps to project a fair market value of Nova Stock properly, considering its historical fundamentals such as Price To Sales. Since Nova Leap's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nova Leap's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nova Leap's interrelated accounts and indicators.
Click cells to compare fundamentals
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Nova Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, Nova Leap Health has a Price To Sales of 0.8377 times. This is 96.09% lower than that of the Health Care Providers & Services sector and 82.11% higher than that of the Health Care industry. The price to sales for all Canada stocks is 92.66% higher than that of the company.
Nova Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nova Leap's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nova Leap could also be used in its relative valuation, which is a method of valuing Nova Leap by comparing valuation metrics of similar companies.Nova Leap is currently under evaluation in price to sales category among its peers.
Nova Leap Current Valuation Drivers
We derive many important indicators used in calculating different scores of Nova Leap from analyzing Nova Leap's financial statements. These drivers represent accounts that assess Nova Leap's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Nova Leap's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 19.9M | 38.3M | 35.9M | 14.3M | 17.5M | 14.3M | |
| Enterprise Value | 24.0M | 41.5M | 40.3M | 17.0M | 18.1M | 16.1M |
Nova Fundamentals
| Return On Equity | -0.0249 | ||||
| Return On Asset | 0.0279 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 21.31 M | ||||
| Shares Outstanding | 86.21 M | ||||
| Shares Owned By Insiders | 40.76 % | ||||
| Number Of Shares Shorted | 12.7 K | ||||
| Price To Book | 0.84 X | ||||
| Price To Sales | 0.84 X | ||||
| Revenue | 26.41 M | ||||
| Gross Profit | 9.98 M | ||||
| EBITDA | 1.23 M | ||||
| Net Income | (1.07 M) | ||||
| Cash And Equivalents | 1.24 M | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 3.97 M | ||||
| Debt To Equity | 64.80 % | ||||
| Current Ratio | 0.58 X | ||||
| Book Value Per Share | 0.21 X | ||||
| Cash Flow From Operations | 1.41 M | ||||
| Short Ratio | 0.72 X | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 0.6 | ||||
| Beta | 1.52 | ||||
| Market Capitalization | 23.28 M | ||||
| Total Asset | 23.95 M | ||||
| Retained Earnings | (1.19 M) | ||||
| Working Capital | (10.37 K) | ||||
| Net Asset | 23.95 M |
About Nova Leap Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nova Leap Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Leap using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Leap Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nova Stock Analysis
When running Nova Leap's price analysis, check to measure Nova Leap's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Leap is operating at the current time. Most of Nova Leap's value examination focuses on studying past and present price action to predict the probability of Nova Leap's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Leap's price. Additionally, you may evaluate how the addition of Nova Leap to your portfolios can decrease your overall portfolio volatility.